{"id":"https://openalex.org/W4388735674","doi":"https://doi.org/10.1007/s13311-023-01453-6","title":"Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop","display_name":"Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4388735674","doi":"https://doi.org/10.1007/s13311-023-01453-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/37973689","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10684835"},"language":"en","primary_location":{"id":"doi:10.1007/s13311-023-01453-6","doi":"https://doi.org/10.1007/s13311-023-01453-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-023-01453-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-023-01453-6.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"volume":null,"type":"erratum","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s13311-023-01453-6.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073027575","display_name":"Diane T. Stephenson","orcid":"https://orcid.org/0000-0002-4262-436X","observed_orcids":["https://orcid.org/0000-0002-4262-436X"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Diane Stephenson","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA. dstephenson@c-path.org","Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":"https://orcid.org/0000-0002-4262-436X","affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA. dstephenson@c-path.org","institution_ids":["https://openalex.org/I2801686373"]},{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028260093","display_name":"Ramona Belfiore","orcid":"https://orcid.org/0000-0003-3380-4972","observed_orcids":["https://orcid.org/0000-0003-3380-4972"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramona Belfiore-Oshan","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076449284","display_name":"Yashmin J.G. Karten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yashmin Karten","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027236213","display_name":"Jessi L. Keavney","orcid":"https://orcid.org/0000-0002-2568-9006","observed_orcids":["https://orcid.org/0000-0002-2568-9006"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessi Keavney","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025482784","display_name":"D. Kevin Kwok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Kevin Kwok","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036680689","display_name":"Terina N. Martinez","orcid":"https://orcid.org/0009-0005-3272-8148","observed_orcids":["https://orcid.org/0009-0005-3272-8148"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terina Martinez","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082598513","display_name":"Joe Montminy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe Montminy","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068115190","display_name":"Martijn L.T.M. M\u00fcller","orcid":"https://orcid.org/0000-0002-1133-7202","observed_orcids":["https://orcid.org/0000-0002-1133-7202"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martijn L.T.M. M\u00fcller","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058044307","display_name":"Klaus Romero","orcid":"https://orcid.org/0000-0002-8576-8638","observed_orcids":["https://orcid.org/0000-0002-8576-8638"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klaus Romero","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055848943","display_name":"Sudhir Sivakumaran","orcid":"https://orcid.org/0000-0002-8586-0469","observed_orcids":["https://orcid.org/0000-0002-8586-0469"]},"institutions":[{"id":"https://openalex.org/I2801686373","display_name":"Critical Path Institute","ror":"https://ror.org/02mgtg880","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801686373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudhir Sivakumaran","raw_affiliation_strings":["Critical Path Institute, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Critical Path Institute, Tucson, AZ, USA","institution_ids":["https://openalex.org/I2801686373"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073027575"],"corresponding_institution_ids":["https://openalex.org/I2801686373"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"6","first_page":"1893","last_page":"1893"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.3384000062942505,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.3384000062942505,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.14149999618530273,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13656","display_name":"Science, Research, and Medicine","score":0.08829999715089798,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.9890000224113464},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.9700000286102295}],"concepts":[{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.6947985887527466},{"id":"https://openalex.org/C12770488","wikidata":"https://www.wikidata.org/wiki/Q188449","display_name":"Neurosurgery","level":2,"score":0.5361447334289551},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.47961485385894775},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.4483616352081299},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44686147570610046},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2914227843284607},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23496127128601074}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s13311-023-01453-6","doi":"https://doi.org/10.1007/s13311-023-01453-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-023-01453-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-023-01453-6.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10684835","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10684835","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10684835/pdf/13311_2023_Article_1453.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"Text"},{"id":"pmid:37973689","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37973689","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","raw_type":"Published Erratum"}],"best_oa_location":{"id":"doi:10.1007/s13311-023-01453-6","doi":"https://doi.org/10.1007/s13311-023-01453-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-023-01453-6","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-023-01453-6.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388735674.pdf","grobid_xml":"https://content.openalex.org/works/W4388735674.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2327547373","https://openalex.org/W4230869579","https://openalex.org/W2000890747","https://openalex.org/W4362602195","https://openalex.org/W4234887320","https://openalex.org/W2990862088","https://openalex.org/W4210997138","https://openalex.org/W3023904227","https://openalex.org/W2042922355","https://openalex.org/W4312984099"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-17T00:00:00"}